Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate.
Shun KanekoMasayuki KurosakiNobuharu TamakiJun ItakuraTsuguru HayashiSakura KirinoLeona OsawaKeiya WatakabeMao OkadaWan WangTakao ShimizuMayu HiguchiKenta TakauraYutaka YasuiKaoru TsuchiyaHiroyuki NakanishiYuka TakahashiMamoru WatanabeNamiki IzumiPublished in: Journal of gastroenterology and hepatology (2019)
Tenofovir disoproxil fumarate and TAF showed adequate antiviral effects as naïve therapies. Furthermore, switching from TDF to TAF therapy contributed to the maintenance of the antiviral effect and recovery of renal dysfunction.